Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

NCT: NCT07632742 · RECRUITING

NCT IDNCT07632742
StatusRECRUITING
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑